Global Chemical CDMO 麻豆原创 Research Report 2024

Publication ID:

PB508249162

Publication Date:

August 26, 2024

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

CDMO, Contract development and manufacturing organization, is an emerging R&D and production outsourcing organization, mainly for the products of medical production enterprises and biotechnology companies, especially the process R&D and preparation of innovative products, process optimization, registration and verification batch production and commercial A service organization for customized R&D and production.
The global Chemical CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chemical CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chemical CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Chemical CDMO in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Chemical CDMO include Lonza, Catalent, GenScript Biotech, Biosynth, Otsuka Chemical, AGC Pharma Chemicals, Jubilant Bhartia Group, Sinopep Allsino Bio Pharmaceutical and Wuxi Biologics (Cayman), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chemical CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical CDMO.
Report Scope
The Chemical CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chemical CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemical CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics
Segment by Type
Small Molecule Preparations
Macromolecule Preparations
Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemical CDMO companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Chemical CDMO 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecule Preparations
1.2.3 Macromolecule Preparations
1.3 麻豆原创 by Application
1.3.1 Global Chemical CDMO 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemical CDMO 麻豆原创 Perspective (2019-2030)
2.2 Chemical CDMO Growth Trends by Region
2.2.1 Global Chemical CDMO 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chemical CDMO Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Chemical CDMO Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Chemical CDMO 麻豆原创 Dynamics
2.3.1 Chemical CDMO Industry Trends
2.3.2 Chemical CDMO 麻豆原创 Drivers
2.3.3 Chemical CDMO 麻豆原创 Challenges
2.3.4 Chemical CDMO 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemical CDMO Players by Revenue
3.1.1 Global Top Chemical CDMO Players by Revenue (2019-2024)
3.1.2 Global Chemical CDMO Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Chemical CDMO 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chemical CDMO Revenue
3.4 Global Chemical CDMO 麻豆原创 Concentration Ratio
3.4.1 Global Chemical CDMO 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemical CDMO Revenue in 2023
3.5 Chemical CDMO Key Players Head office and Area Served
3.6 Key Players Chemical CDMO Product Solution and Service
3.7 Date of Enter into Chemical CDMO 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemical CDMO Breakdown Data by Type
4.1 Global Chemical CDMO Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Chemical CDMO Forecasted 麻豆原创 Size by Type (2025-2030)
5 Chemical CDMO Breakdown Data by Application
5.1 Global Chemical CDMO Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Chemical CDMO Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Chemical CDMO 麻豆原创 Size (2019-2030)
6.2 North America Chemical CDMO 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chemical CDMO 麻豆原创 Size by Country (2019-2024)
6.4 North America Chemical CDMO 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemical CDMO 麻豆原创 Size (2019-2030)
7.2 Europe Chemical CDMO 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chemical CDMO 麻豆原创 Size by Country (2019-2024)
7.4 Europe Chemical CDMO 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemical CDMO 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Chemical CDMO 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chemical CDMO 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Chemical CDMO 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemical CDMO 麻豆原创 Size (2019-2030)
9.2 Latin America Chemical CDMO 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chemical CDMO 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Chemical CDMO 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemical CDMO 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Chemical CDMO 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chemical CDMO 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Chemical CDMO 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Chemical CDMO Introduction
11.1.4 Lonza Revenue in Chemical CDMO Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Chemical CDMO Introduction
11.2.4 Catalent Revenue in Chemical CDMO Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 GenScript Biotech
11.3.1 GenScript Biotech Company Detail
11.3.2 GenScript Biotech Business Overview
11.3.3 GenScript Biotech Chemical CDMO Introduction
11.3.4 GenScript Biotech Revenue in Chemical CDMO Business (2019-2024)
11.3.5 GenScript Biotech Recent Development
11.4 Biosynth
11.4.1 Biosynth Company Detail
11.4.2 Biosynth Business Overview
11.4.3 Biosynth Chemical CDMO Introduction
11.4.4 Biosynth Revenue in Chemical CDMO Business (2019-2024)
11.4.5 Biosynth Recent Development
11.5 Otsuka Chemical
11.5.1 Otsuka Chemical Company Detail
11.5.2 Otsuka Chemical Business Overview
11.5.3 Otsuka Chemical Chemical CDMO Introduction
11.5.4 Otsuka Chemical Revenue in Chemical CDMO Business (2019-2024)
11.5.5 Otsuka Chemical Recent Development
11.6 AGC Pharma Chemicals
11.6.1 AGC Pharma Chemicals Company Detail
11.6.2 AGC Pharma Chemicals Business Overview
11.6.3 AGC Pharma Chemicals Chemical CDMO Introduction
11.6.4 AGC Pharma Chemicals Revenue in Chemical CDMO Business (2019-2024)
11.6.5 AGC Pharma Chemicals Recent Development
11.7 Jubilant Bhartia Group
11.7.1 Jubilant Bhartia Group Company Detail
11.7.2 Jubilant Bhartia Group Business Overview
11.7.3 Jubilant Bhartia Group Chemical CDMO Introduction
11.7.4 Jubilant Bhartia Group Revenue in Chemical CDMO Business (2019-2024)
11.7.5 Jubilant Bhartia Group Recent Development
11.8 Sinopep Allsino Bio Pharmaceutical
11.8.1 Sinopep Allsino Bio Pharmaceutical Company Detail
11.8.2 Sinopep Allsino Bio Pharmaceutical Business Overview
11.8.3 Sinopep Allsino Bio Pharmaceutical Chemical CDMO Introduction
11.8.4 Sinopep Allsino Bio Pharmaceutical Revenue in Chemical CDMO Business (2019-2024)
11.8.5 Sinopep Allsino Bio Pharmaceutical Recent Development
11.9 Wuxi Biologics (Cayman)
11.9.1 Wuxi Biologics (Cayman) Company Detail
11.9.2 Wuxi Biologics (Cayman) Business Overview
11.9.3 Wuxi Biologics (Cayman) Chemical CDMO Introduction
11.9.4 Wuxi Biologics (Cayman) Revenue in Chemical CDMO Business (2019-2024)
11.9.5 Wuxi Biologics (Cayman) Recent Development
11.10 Porton Fine Chemicals
11.10.1 Porton Fine Chemicals Company Detail
11.10.2 Porton Fine Chemicals Business Overview
11.10.3 Porton Fine Chemicals Chemical CDMO Introduction
11.10.4 Porton Fine Chemicals Revenue in Chemical CDMO Business (2019-2024)
11.10.5 Porton Fine Chemicals Recent Development
11.11 Zhejiang Jiuzhou Pharmaceutical
11.11.1 Zhejiang Jiuzhou Pharmaceutical Company Detail
11.11.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.11.3 Zhejiang Jiuzhou Pharmaceutical Chemical CDMO Introduction
11.11.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Chemical CDMO Business (2019-2024)
11.11.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
11.12 NYCRIST
11.12.1 NYCRIST Company Detail
11.12.2 NYCRIST Business Overview
11.12.3 NYCRIST Chemical CDMO Introduction
11.12.4 NYCRIST Revenue in Chemical CDMO Business (2019-2024)
11.12.5 NYCRIST Recent Development
11.13 Guangzhou Bositao Controlled Release Pharmaceutical
11.13.1 Guangzhou Bositao Controlled Release Pharmaceutical Company Detail
11.13.2 Guangzhou Bositao Controlled Release Pharmaceutical Business Overview
11.13.3 Guangzhou Bositao Controlled Release Pharmaceutical Chemical CDMO Introduction
11.13.4 Guangzhou Bositao Controlled Release Pharmaceutical Revenue in Chemical CDMO Business (2019-2024)
11.13.5 Guangzhou Bositao Controlled Release Pharmaceutical Recent Development
11.14 Charles River
11.14.1 Charles River Company Detail
11.14.2 Charles River Business Overview
11.14.3 Charles River Chemical CDMO Introduction
11.14.4 Charles River Revenue in Chemical CDMO Business (2019-2024)
11.14.5 Charles River Recent Development
11.15 Cambrex
11.15.1 Cambrex Company Detail
11.15.2 Cambrex Business Overview
11.15.3 Cambrex Chemical CDMO Introduction
11.15.4 Cambrex Revenue in Chemical CDMO Business (2019-2024)
11.15.5 Cambrex Recent Development
11.16 Almac Group
11.16.1 Almac Group Company Detail
11.16.2 Almac Group Business Overview
11.16.3 Almac Group Chemical CDMO Introduction
11.16.4 Almac Group Revenue in Chemical CDMO Business (2019-2024)
11.16.5 Almac Group Recent Development
11.17 Jubilant Pharmova
11.17.1 Jubilant Pharmova Company Detail
11.17.2 Jubilant Pharmova Business Overview
11.17.3 Jubilant Pharmova Chemical CDMO Introduction
11.17.4 Jubilant Pharmova Revenue in Chemical CDMO Business (2019-2024)
11.17.5 Jubilant Pharmova Recent Development
11.18 Cambrex
11.18.1 Cambrex Company Detail
11.18.2 Cambrex Business Overview
11.18.3 Cambrex Chemical CDMO Introduction
11.18.4 Cambrex Revenue in Chemical CDMO Business (2019-2024)
11.18.5 Cambrex Recent Development
11.19 Siegfried Holding AG
11.19.1 Siegfried Holding AG Company Detail
11.19.2 Siegfried Holding AG Business Overview
11.19.3 Siegfried Holding AG Chemical CDMO Introduction
11.19.4 Siegfried Holding AG Revenue in Chemical CDMO Business (2019-2024)
11.19.5 Siegfried Holding AG Recent Development
11.20 Aenova Group
11.20.1 Aenova Group Company Detail
11.20.2 Aenova Group Business Overview
11.20.3 Aenova Group Chemical CDMO Introduction
11.20.4 Aenova Group Revenue in Chemical CDMO Business (2019-2024)
11.20.5 Aenova Group Recent Development
11.21 Samsung BioLogics
11.21.1 Samsung BioLogics Company Detail
11.21.2 Samsung BioLogics Business Overview
11.21.3 Samsung BioLogics Chemical CDMO Introduction
11.21.4 Samsung BioLogics Revenue in Chemical CDMO Business (2019-2024)
11.21.5 Samsung BioLogics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.